Delivery Order SPE2DB24D2212-SPE2DB25FHQFT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 18, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract value of $11,992.10 and completion date of March 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,649.76 for 1,000 tablets of Januvia 100 mg on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of 1,000 tablets of Januvia 100 mg with a ceiling value of $23,808.76. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $41,746.13 for 1,000 tablets of Januvia 100 mg on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Januvia is an oral antidiabetic medication commonly...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $1,066.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes management medication, under a firm fixed-price contract valued at $4,514.50. The order, placed on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) on August 14, 2025, with completion targeted for August 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $79,957.75 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a pharmaceutical product commonly prescribed for diabetes management. The contract was awarded on July 17, 2025, with an ultimate completion date of July 18, 2025, under a firm fixed price arrangement. This non-set-aside delivery order represents a competitively awarded transaction for pharmaceutical supplies supporting federal medical procurement needs. This...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQFTDelivery Order
The Defense Logistics Agency awarded a $34,120.38 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with completion scheduled for July 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military and federal healthcare programs. Januvia (sitagliptin) is a widely prescribed diabetes medication used to manage type 2 diabetes in patients requiring pharmaceutical intervention. This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen Drug Corp's extensive portfolio of medications supplied to the Defense Health Agency and other federal healthcare systems. The company's role as a pharmaceutical prime vendor enables efficient distribution of both brand-name and generic medications across multiple therapeutic domains to support military healthcare operations globally, with this specific order fulfilling near-term medical supply requirements for federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 7/14/25 |